Avalo Therapeutics, Inc. Annual General and Administrative Expense in USD from 2013 to 2022

Taxonomy & unit
us-gaap: USD
Description
The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.
Summary
Avalo Therapeutics, Inc. quarterly/annual General and Administrative Expense history and growth rate from 2013 to 2022.
  • Avalo Therapeutics, Inc. General and Administrative Expense for the quarter ending September 30, 2024 was $4.29M, a 72.1% increase year-over-year.
  • Avalo Therapeutics, Inc. annual General and Administrative Expense for 2022 was $20.7M, a 16% decline from 2021.
  • Avalo Therapeutics, Inc. annual General and Administrative Expense for 2021 was $24.7M, a 41.6% increase from 2020.
  • Avalo Therapeutics, Inc. annual General and Administrative Expense for 2020 was $17.4M, a 72.1% increase from 2019.
General and Administrative Expense, Trailing 12 Months (USD)
General and Administrative Expense, Annual (USD)
General and Administrative Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2022 $20.7M -$3.95M -16% Jan 1, 2022 Dec 31, 2022 10-K 2023-03-29
2021 $24.7M +$7.24M +41.6% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-29
2020 $17.4M +$7.29M +72.1% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-02
2019 $10.1M -$388K -3.69% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-08
2018 $10.5M +$2.57M +32.4% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-11
2017 $7.94M +$858K +12.1% Jan 1, 2017 Dec 31, 2017 10-K 2019-03-18
2016 $7.08M +$2.66M +60.2% Jan 1, 2016 Dec 31, 2016 10-K 2018-04-02
2015 $4.42M -$452K -9.28% Jan 1, 2015 Dec 31, 2015 10-K 2018-04-02
2014 $4.88M +$855K +21.3% Jan 1, 2014 Dec 31, 2014 10-K 2017-03-14
2013 $4.02M Jan 1, 2013 Dec 31, 2013 10-K 2016-03-23
* An asterisk sign (*) next to the value indicates that the value is likely invalid.